Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact
- Whistleblowers

Pharmacological inhibition of chitotriosidase (CHIT1) as a novel therapeutic approach for sarcoidosis I 12-16 June, 2022, Keystone, CO, USA

About us

Molecure is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.